Treatment of Lenalidomide Exposed or Refractory Multiple Myeloma: Network Meta-Analysis of Lenalidomide-Sparing Regimens

Overview of attention for article published in Frontiers in oncology, April 2021

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (70th percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 9 X posts from 5 X users, with an upper bound of 17,435 followers.

RT @FrontOncology: 💭 What is the best approach for the treatment of lenalidomide exposed or refractory multiple myeloma? Find out here ➡ h…

💭 What is the best approach for the treatment of lenalidomide exposed or refractory multiple myeloma? Find out here ➡ https://t.co/SjBps8SSom #MyelomaAwarenessMonth #MultipleMyeloma #MMsm #HemOnc https://t.co/ueRwO535hi

⭐ Top Opinion 2021 #2: Treatment of Lenalidomide Exposed or Refractory #MultipleMyeloma: Network #MetaAnalysis of Lenalidomide-Sparing Regimens 👨‍⚕️👩‍⚕️ @cirobotta2 et al 👉 https://t.co/FH7KVmDZwb @DottorClaudio @GMartinelli2 #HemOnc #lenalidomide

RT @FrontOncology: Read now 📄 Treatment of Lenalidomide Exposed or Refractory #MultipleMyeloma: Network Meta-Analysis of Lenalidomide-Spari…

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 5 additional X posts.